Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance

OL study: Blonanserin, a D2, D3, and 5-HT2A r. antag., was efficacious in 1,018 Chinese patients with schizophrenia (BPRS-12 weeks= −20.6; response = 53.5%). Incidence of AEs (12 weeks): EPS (16.6%), akathisia (8.8%), ≥7% increase in body weight (4.0%) htt

New Research: Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing Surveillance: Schizophrenia is an unexplained, complex and… https://t.co/un0H6